INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 2 filers reported holding INHIBRX INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $383,931 | – | 10,982 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,279,995 | $22,976,000 | 5.44% |
| Opaleye Management Inc. | 292,700 | $5,254,000 | 2.17% |
| Perceptive Advisors | 2,887,860 | $51,837,000 | 1.50% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 645,815 | $11,592,000 | 1.11% |
| Birchview Capital, LP | 70,448 | $1,265,000 | 0.89% |
| Soleus Capital Management, L.P. | 363,902 | $6,532,000 | 0.89% |
| Meridian Wealth Advisors, LLC | 122,315 | $2,196,000 | 0.62% |
| Sofinnova Investments, Inc. | 450,177 | $8,081,000 | 0.47% |
| VIKING GLOBAL INVESTORS LP | 5,305,866 | $95,240,000 | 0.44% |
| Sofinnova Investments, Inc. | 350,000 | $6,283,000 | 0.37% |